Increased notch pathway activation in Behçet's disease

Rheumatology (United Kingdom)

Volumn 53, Issue 5, 2014, Pages 810-820

  Qi, Jian ^a,b,c   Yang, Yan ^a,b,c   Hou, Shengping ^a,b,c   Qiao, Yanbin ^a,b,c   Wang, Qian ^a,b,c   Yu, Hongsong ^a,b,c   Zhang, Qi ^a,b,c   Cai, Tao ^a,b,c   Kijlstra, Aize ^d   Yang, Peizeng ^a,b,c  

^a CHONGQING MEDICAL UNIVERSITY   (China)

^b Chongqing Key Laboratory of Ophthalmology   (China)

^c Chongqing Eye Institute   (China)

^d MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Autoinflammatory conditions; Beh et's; Cell receptor ligand interaction; Cytokines and inflammatory mediators; Inflammation; Lymphocytes; MicroRNA; Molecular biology; Ophthalmic; Signalling and activation; T cells

Indexed keywords

CHLORAMBUCIL; CORTICOSTEROID DERIVATIVE; CYCLOSPORIN A; DLL 1 PROTEIN; DLL 4 PROTEIN; GAMMA INTERFERON; GAMMA SECRETASE INHIBITOR; INTERLEUKIN 17; JAGGED1; MICRORNA; MICRORNA 23B; N [N (3,5 DIFLUOROPHENACETYL) 1 ALANYL] S PHENYLGLYCINE TERT BUTYL ESTER; NOTCH RECEPTOR; NOTCH1 RECEPTOR; NOTCH2 RECEPTOR; NOTCH3 RECEPTOR; NOTCH4 RECEPTOR; STAT3 PROTEIN; TRANSCRIPTION FACTOR HES 1; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BEHCET DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; CORTICOSTEROID THERAPY; CYTOKINE PRODUCTION; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IMMUNE RESPONSE; LOW DRUG DOSE; LYMPHOCYTE DIFFERENTIATION; MALE; MOTCH PATHWAY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; SYSTEMIC THERAPY; T CELL CULTURE; TH17 CELL; UVEITIS;

AUTOINFLAMMATORY CONDITIONS; BEHÇET'S; CELL RECEPTOR-LIGAND INTERACTION; CYTOKINES AND INFLAMMATORY MEDIATORS; INFLAMMATION; LYMPHOCYTES; MICRORNA; MOLECULAR BIOLOGY; OPHTHALMIC; SIGNALLING AND ACTIVATION; T CELLS;

ADULT; BEHCET SYNDROME; CASE-CONTROL STUDIES; CD4-POSITIVE T-LYMPHOCYTES; CELLS, CULTURED; CYTOKINES; FEMALE; HUMANS; MALE; MICRORNAS; RECEPTORS, NOTCH; SIGNAL TRANSDUCTION; STAT3 TRANSCRIPTION FACTOR; TH1 CELLS; TH17 CELLS;

EID: 84898771879     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/ket438     Document Type: Article

References (44)

1. Suttorp-Schulten MS, Rothova A. The possible impact of uveitis in blindness: a literature survey. Br J Ophthalmol 1996;80:844-8.
2. Yang P, Fang W, Meng Q et al. Clinical features of Chinese patients with Behçet's disease. Ophthalmology 2008; 115:312-8.e4.
3. Khairallah M, Accorinti M, Muccioli C et al. Epidemiology of Behçet disease. Ocul Immunol Inflamm 2012;20: 324-35.
4. Hamzaoui K, Hamzaoui A, Guemira F et al. Cytokine profile in Behçet's disease patients. Relationship with disease activity. Scand J Rheumatol 2002;31:205-10.
5. Hamzaoui K, Bouali E, Ghorbel I et al. Expression of Th-17 and RORgammat mRNA in Behçet's disease. Med Sci Monit 2011;17:CR227-34.
6. Hamzaoui K. Th17 cells in Behçet's disease: a new immunoregulatory axis. Clin Exp Rheumatol 2011;29: S71-6.
7. Keerthivasan S, Suleiman R, Lawlor R et al. Notch signaling regulates mouse and human Th17 differentiation. J Immunol 2011;187:692.
8. Radtke F, Fasnacht N, MacDonald HR. Notch signaling in the immune system. Immunity 2010;32:14-27.
9. Kopan R, Ilagan MXG. The canonical Notch signaling pathway: unfolding the activation mechanism. Cell 2009; 137:216-33.
10. Radtke F, Wilson A, Mancini SJC et al. Notch regulation of lymphocyte development and function. Nat Immunol 2004;5:247-53.
11. Pear WS, Aster JC. T cell acute lymphoblastic leukemia/ lymphoma: a human cancer commonly associated with aberrant NOTCH1 signaling. Curr Opin Hematol 2004;11: 426.
12. Minter LM, Turley DM, Das P et al. Inhibitors of g-secretase block in vivo and in vitro T helper type 1 polarization by preventing Notch upregulation of Tbx21. Nature immunology 2005;6:680-8.
13. Fang TC, Yashiro-Ohtani Y, Del Bianco C et al. Notch directly regulates Gata3 expression during T helper 2 cell differentiation. Immunity 2007;27:100-10.
14. Dees C, Zerr P, Tomcik M et al. Inhibition of Notch signaling prevents experimental fibrosis and induces regression of established fibrosis. Arthritis Rheum 2011; 63:1396-404.
15. Gao W, Sweeney C, Connolly M et al. Notch-1 mediates hypoxia-induced angiogenesis in rheumatoid arthritis. Arthritis Rheum 2012;64:2104-13.
16. Jiao Z, Wang W, Guo M et al. Expression analysis of Notch-related molecules in peripheral blood T helper cells of patients with rheumatoid arthritis. Scand J Rheumatol 2010;39:26-32.
17. Piggott K, Deng J, Warrington K et al. Blocking the NOTCH pathway inhibits vascular inflammation in largevessel vasculitis. Circulation 2011;123:309-18.
18. Bassil R, Zhu B, Lahoud Y et al. Notch ligand delta-like 4 blockade alleviates experimental autoimmune encephalomyelitis by promoting regulatory T cell development. J Immunol 2011;187:2322-8.
19. Ishida W, Fukuda K, Sakamoto S et al. Regulation of experimental autoimmune uveoretinitis by anti-delta-like ligand 4 monoclonal antibody. Invest Ophthalmol Vis Sci 2011;52:8224-30.
20. Criteria for diagnosis of Behçet's disease. International Study Group for Behçet's Disease. Lancet 1990;335: 1078-80.
21. Nakano N, Nishiyama C, Yagita H et al. Notch signaling confers antigen-presenting cell functions on mast cells. J Allergy Clin Immunol 2009;123:74-81.e1.
22. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 2001;25:402-8.
23. Chi W, Zhu X, Yang P et al. Upregulated IL-23 and IL-17 in Behçet patients with active uveitis. Invest Ophthalmol Vis Sci 2008;49:3058-64.
24. Wang Z, Li Y, Kong D et al. Cross-talk between miRNA and Notch signaling pathways in tumor development and progression. Cancer Lett 2010;292:141-8.
25. Pang RT, Leung CO, Ye TM et al. MicroRNA-34a suppresses invasion through downregulation of Notch1 and Jagged1 in cervical carcinoma and choriocarcinoma cells. Carcinogenesis 2010;31:1037-44.
26. Fukuda Y, Kawasaki H, Taira K. Exploration of human miRNA target genes in neuronal differentiation. Nucleic Acids Symp Ser 2005;341-2.
27. Zheng J, Jiang HY, Li J et al. MicroRNA-23b promotes tolerogenic properties of dendritic cells in vitro through inhibiting Notch1/NF-kB signalling pathways. Allergy 2012;67:362-70.
28. Hashimi ST, Fulcher JA, Chang MH et al. MicroRNA profiling identifies miR-34a and miR-21 and their target genes JAG1 and WNT1 in the coordinate regulation of dendritic cell differentiation. Blood 2009;114:404-14.
29. Palaga T, Miele L, Golde TE et al. TCR-mediated Notch signaling regulates proliferation and IFN-gamma production in peripheral T cells. J Immunol 2003;171: 3019-24.
30. Zeng Q, Jin C, Ao L et al. Cross-talk between the Toll-like receptor 4 and Notch1 pathways augments the inflammatory response in the interstitial cells of stenotic human aortic valves. Circulation 2012;126:S222-30.
31. Bansal K, Balaji KN. Intracellular pathogen sensor NOD2 programs macrophages to trigger Notch1 activation. J Biol Chem 2011;286:5823-35.
32. Kirino Y, Takeno M, Watanabe R et al. Association of reduced heme oxygenase-1 with excessive Toll-like receptor 4 expression in peripheral blood mononuclear cells in Behçet's disease. Arthritis Res Ther 2008;10:R16.
33. Hamzaoui K, Abid H, Berraies A et al. NOD2 is highly expressed in Behçet disease with pulmonary manifestations. J Inflamm 2012;9:3.
34. Hamzaoui K, Borhani Haghighi A, Ghorbel IB et al. RORC and Foxp3 axis in cerebrospinal fluid of patients with neuro-Behçet's disease. J Neuroimmunol 2011;233: 249-53.
35. Kang JH, Kim BS, Uhm TG et al. g-Secretase inhibitor reduces allergic pulmonary inflammation by modulating Th1 and Th2 responses. Am J Respir Crit Care Med 2009; 179:875-82.
36. Mathur AN, Chang HC, Zisoulis DG et al. Stat3 and Stat4 direct development of IL-17-secreting Th cells. J Immunol 2007;178:4901.
37. Kamakura S, Oishi K, Yoshimatsu T et al. Hes binding to STAT3 mediates crosstalk between Notch and JAK-STAT signalling. Nat Cell Biol 2004;6:547-54.
38. Bhoopathi P, Chetty C, Dontula R et al. SPARC stimulates neuronal differentiation of medulloblastoma cells via the Notch1/STAT3 pathway. Cancer Res 2011;71: 4908.
39. Du C, Liu C, Kang J et al. MicroRNA miR-326 regulates TH-17 differentiation and is associated with the pathogenesis of multiple sclerosis. Nat Immunol 2009;10: 1252-9.
40. Lu LF, Boldin MP, Chaudhry A et al. Function of miR-146a in controlling Treg cell-mediated regulation of Th1 responses. Cell 2010;142:914-29.
41. O'Connell RM, Kahn D, Gibson WSJ et al. MicroRNA-155 promotes autoimmune inflammation by enhancing inflammatory T cell development. Immunity 2010;33: 607-19.
42. Nanke Y, Kotake S, Goto M et al. Decreased percentages of regulatory T cells in peripheral blood of patients with Behçet's disease before ocular attack: a possible predictive marker of ocular attack. Mod Rheumatol 2008;18:354-8.
43. Zhu S, Pan W, Song X et al. The microRNA miR-23b suppresses IL-17-associated autoimmune inflammation by targeting TAB2, TAB3 and IKK-alpha. Nat Med 2012; 18:1077-86.
44. Sarica-Kucukoglu R, Akdag-Kose A, Kayabal IM et al. Vascular involvement in Behçet's disease: a retrospective analysis of 2319 cases. Int J Dermatol 2006;45:919-21.